Open AccessNew antibiotics in the treatment of urinary tract infections
Author(s) -
Florian Wagenlehner
Publication year - 2021
Publication title -
urologìâ
Language(s) - English
Resource type - Journals
eISSN - 2709-5576
pISSN - 2307-5279
DOI - 10.26641/2307-5279.25.2.2021.238219
Subject(s) - fosfomycin , antibiotics , cephalosporin , medicine , aminoglycoside , urinary system , antibiotic resistance , intensive care medicine , microbiology and biotechnology , biology
Antibiotics are very often prescribed for the indication urinary tract infections (UTIs). Therefore, UTIs are an important field for the development of antibiotic resistance. A number of new antibiotics have been tested for the indication complicated UTI / pyelonephritis. These are cephalosporins and carbapenems, in combination with new beta-lactamase inhibitors, cefiderocol as a new type of cephalosporin, plazomicin a new aminoglycoside, eravacycline a new tetracycline, and intravenous fosfomycin. Not all antibiotics are approved in Europe. Although the development of these new substances is promising, these new antibiotics should be used very carefully to avoid the development of new antibiotic resistance against these new substances.